Comparison of Two Different Types of "Spray as You go" Technique for Awake

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05736198` - Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation
Recruiting	`NCT05320731` - Atomization vs. Nebulization for Airway Topicalization During Awake Nasotracheal Fiberoptic Intubation	N/A
Completed	`NCT00383890` - A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation	Phase 3

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT05736198 - Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation

Recruiting

NCT05320731 - Atomization vs. Nebulization for Airway Topicalization During Awake Nasotracheal Fiberoptic Intubation

N/A

Completed

NCT00383890 - A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01995292
Study type	Interventional
Source	Johannes Gutenberg University Mainz
Contact
Status	Completed
Phase	N/A
Start date	October 2013
Completion date	October 2014

Comparison of Two Different Types of "Spray as You go" Technique for Awake Fiberoptic Intubation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms